Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative Intra-nasal Dexmedetomidine or Insulin for Prevention of Early Post-operative Cognitive Dysfunction in CABG
NCT06741566Phase 1Completed
- Sponsor
- Minia University
- Start
- Dec 2024
- Primary completion
- May 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine and Generex Oral-lyn in cognitive dysfunction (3 arms), sponsored by Minia University. Primary endpoint: Mini mental state examination. Started Dec 2024; status: completed.
02
Drugs
dexmedetomidineGenerex Oral-lyn
03
Conditions
cognitive dysfunction
Beyond the preview
Go deeper on NCT06741566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06741566.